Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Bee venom induces apoptosis through intracellular Ca2+ -modulated intrinsic death pathway in human bladder cancer cells.
Ip SW, Chu YL, Yu CS, Chen PY, Ho HC, Yang JS, Huang HY, Chueh FS, Lai TY, Chung JG.
Int J Urol. 2012 Jan;19(1):61-70. doi: 10.1111/j.1442-2042.2011.02876.x. Epub 2011 Dec 11.
Related citations
Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors.
Takayanagi A, Masumori N, Takahashi A, Takagi Y, Tsukamoto T.
Int J Urol. 2012 Mar;19(3):229-33. doi: 10.1111/j.1442-2042.2011.02916.x. Epub 2011 Nov 28.
p130Cas, E-cadherin and β-catenin in human transitional cell carcinoma of the bladder: expression and clinicopathological significance.
Hu X, Ruan Y, Cheng F, Yu W, Zhang X, Larré S.
Int J Urol. 2011 Sep;18(9):630-7. doi: 10.1111/j.1442-2042.2011.02793.x. Epub 2011 Jun 14.
Lymphoepithelioma-like bladder cancer: clinicopathologic study of six cases.
Kozyrakis D, Petraki C, Prombonas I, Grigorakis A, Kanellis G, Malovrouvas D.
Int J Urol. 2011 Oct;18(10):731-4. doi: 10.1111/j.1442-2042.2011.02825.x. Epub 2011 Aug 4.
Older patients suffer from adverse histopathological features after radical cystectomy.
Rink M, Dahlem R, Kluth L, Minner S, Ahyai SA, Eichelberg C, Fisch M, Chun FKh.
Int J Urol. 2011 Aug;18(8):576-84. doi: 10.1111/j.1442-2042.2011.02794.x. Epub 2011 Jun 23.
Immunohistochemical biomarkers for bladder cancer prognosis.
Matsushita K, Cha EK, Matsumoto K, Baba S, Chromecki TF, Fajkovic H, Sun M, Karakiewicz PI, Scherr DS, Shariat SF.
Int J Urol. 2011 Sep;18(9):616-29. doi: 10.1111/j.1442-2042.2011.02809.x. Epub 2011 Jul 20.
Overexpression of Eg5 predicts unfavorable prognosis in non-muscle invasive bladder urothelial carcinoma.
Ding S, Xing N, Lu J, Zhang H, Nishizawa K, Liu S, Yuan X, Qin Y, Liu Y, Ogawa O, Nishiyama H.
Int J Urol. 2011 Jun;18(6):432-8. doi: 10.1111/j.1442-2042.2011.02751.x. Epub 2011 Mar 30.
Editorial comment to paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens.
El-Gamal OM.
Int J Urol. 2011 May;18(5):357. doi: 10.1111/j.1442-2042.2011.02727.x. Epub 2011 Mar 31. No abstract available.
Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens.
Joung JY, Kwon WA, Cho IC, Kim EK, Park S, Yoon H, Seo HK, Chung J, Park WS, Lee KH.
Int J Urol. 2011 May;18(5):350-7. doi: 10.1111/j.1442-2042.2011.02735.x. Epub 2011 Mar 1.
Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non-muscle invasive bladder cancer.
Shin YS, Kim SD, Cha JS, Kim MK, Jeong YB, Kim HJ.
Int J Urol. 2011 Jun;18(6):439-43. doi: 10.1111/j.1442-2042.2011.02766.x. Epub 2011 Apr 11.
Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 24 cases.
Edgerton N, Sirintrapun SJ, Munoz M, Chen Z, Osunkoya AO.
Int J Urol. 2011 Jan;18(1):49-54. doi: 10.1111/j.1442-2042.2010.02672.x. Epub 2010 Nov 29.
Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer.
Sylvester RJ.
Int J Urol. 2011 Feb;18(2):113-20. doi: 10.1111/j.1442-2042.2010.02678.x. Epub 2010 Nov 22. Review.
Editorial Comment to Cancer death from non-muscle invasive bladder cancer: Report of the Japanese Urological Association of data from the 1999-2001 registry in Japan.
Koga F.
Int J Urol. 2010 Nov;17(11):913. doi: 10.1111/j.1442-2042.2010.02640.x. No abstract available.
Cancer death from non-muscle invasive bladder cancer: report of the Japanese Urological Association of data from the 1999-2001 registry in Japan.
Okajima E, Fujimoto H, Mizutani Y, Kikuchi E, Koga H, Hinotsu S, Shinohara N, Miki T; Cancer Registration Committee of the Japanese Urological Association.
Int J Urol. 2010 Nov;17(11):905-12. doi: 10.1111/j.1442-2042.2010.02633.x. Epub 2010 Oct 5.
Prostatorectal fistula following intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the urinary bladder.
Enatsu N, Ota T, Ochi A.
Int J Urol. 2010 Sep;17(9):822-3. No abstract available.
Editorial comment to Inverse expression of estrogen receptor-beta and nuclear factor-kappaB in urinary bladder carcinogenesis.
Horie S.
Int J Urol. 2010 Sep;17(9):810. No abstract available.
Inverse expression of estrogen receptor-beta and nuclear factor-kappaB in urinary bladder carcinogenesis.
Kontos S, Kominea A, Melachrinou M, Balampani E, Sotiropoulou-Bonikou G.
Int J Urol. 2010 Sep;17(9):801-9.
Editorial comment to Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group.
Mostafid H.
Int J Urol. 2010 Sep;17(9):766-7. No abstract available.
Vesical dermoid: an unusual presentation.
Jain SK, Kaza RC, Vindal A, Bains L.
Int J Urol. 2010 Sep;17(9):824-5. Epub 2010 Jul 13. No abstract available.
Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group.
Koga H, Ozono S, Tsushima T, Tomita K, Horiguchi Y, Usami M, Hirao Y, Akaza H, Naito S; BCG Tokyo Strain Study Group.
Int J Urol. 2010 Sep;17(9):759-66. Epub 2010 Jul 4.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on